These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 7634618

  • 21. [Medical treatment of malignant hypercalcemia].
    Eto S, Nakano Y, Okada Y.
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844
    [Abstract] [Full Text] [Related]

  • 22. Hypercalcemia of malignancy: pathophysiology and implications for treatment.
    Theriault RL.
    Oncology (Williston Park); 1993 Jan; 7(1):47-50; discussion 52-5. PubMed ID: 8420542
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Hypercalcemia and neoplasms: recent advances in pathogenesis].
    Virgolini L, Gallizia C.
    Recenti Prog Med; 1990 Oct; 81(10):635-41. PubMed ID: 2291007
    [Abstract] [Full Text] [Related]

  • 29. [Malignancy-associated hypercalcemia].
    Oura S.
    Nihon Rinsho; 2003 Jun; 61(6):1006-9. PubMed ID: 12806951
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of zoledronic acid in the treatment of bone metastases associated with lung cancer and other solid tumors.
    Rosen LS.
    Semin Oncol; 2002 Dec; 29(6 Suppl 21):28-32. PubMed ID: 12584692
    [Abstract] [Full Text] [Related]

  • 33. The potential role of bisphosphonates in prostate cancer.
    Oades GM, Coxon J, Colston KW.
    Prostate Cancer Prostatic Dis; 2002 Dec; 5(4):264-72. PubMed ID: 12627210
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Biphosphonates in the treatment of osteolytic metastasis. Essential actions on hypercalcemia and important on lytic lesions].
    Liens D, Delmas PD.
    Rev Prat; 1993 May 15; 43(10):1259-61. PubMed ID: 8235365
    [No Abstract] [Full Text] [Related]

  • 37. Management of hypercalcemia in breast cancer.
    Theriault RL.
    Oncology (Williston Park); 1990 Feb 15; 4(2):43-6; discussion 50. PubMed ID: 2143669
    [Abstract] [Full Text] [Related]

  • 38. Breast cancer bone metastasis and current small therapeutics.
    Cicek M, Oursler MJ.
    Cancer Metastasis Rev; 2006 Dec 15; 25(4):635-44. PubMed ID: 17160709
    [Abstract] [Full Text] [Related]

  • 39. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
    Paterson AH, Kanis JA, Powles TJ, McCloskey E, Hanson J, Ashley S.
    Can J Oncol; 1995 Dec 15; 5 Suppl 1():54-7. PubMed ID: 8853526
    [Abstract] [Full Text] [Related]

  • 40. Malignancy and the skeleton.
    Mundy GR.
    Horm Metab Res; 1997 Mar 15; 29(3):120-7. PubMed ID: 9137982
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.